Published in J Virol on December 17, 2008
Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A (2010) 6.72
The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog (2012) 2.45
Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol (2009) 2.20
Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev (2011) 1.66
Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One (2010) 1.63
Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia (2009) 1.59
A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog (2011) 1.51
The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology (2011) 1.45
Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol (2009) 1.41
microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res (2010) 1.32
Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation. J Virol (2010) 1.27
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog (2011) 1.26
Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virol J (2010) 1.18
Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin Cancer Biol (2009) 1.16
Comprehensive analysis of Rhesus lymphocryptovirus microRNA expression. J Virol (2010) 1.09
The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol (2011) 1.06
Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci (2010) 1.05
Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol (2009) 1.04
Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. MBio (2014) 1.04
Viral miRNAs and immune evasion. Biochim Biophys Acta (2011) 1.02
The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog (2015) 0.98
Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers. Int J Cell Biol (2012) 0.98
Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol (2013) 0.97
miRNAs in the pathogenesis of oncogenic human viruses. Cancer Lett (2010) 0.96
Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther (2013) 0.96
MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell lymphomas by deep sequencing. PLoS One (2012) 0.95
Cytomegalovirus microRNA expression is tissue specific and is associated with persistence. J Virol (2010) 0.95
MicroRNAs in nasopharyngeal carcinoma. Chin J Cancer (2014) 0.94
Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma. Nat Commun (2015) 0.94
Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems. FEBS Open Bio (2014) 0.93
Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients--evidence of non-exosomal transport. Virol J (2013) 0.93
Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis (2013) 0.92
Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma. Ther Clin Risk Manag (2014) 0.92
Identification and expression analysis of herpes B virus-encoded small RNAs. J Virol (2011) 0.91
Epstein-Barr virus microRNAs and lung cancer. Br J Cancer (2011) 0.91
The role of microRNAs in Epstein-Barr virus latency and lytic reactivation. Microbes Infect (2011) 0.90
Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol J (2013) 0.90
Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis. J Virol (2015) 0.89
Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. J Virol (2014) 0.87
Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS One (2011) 0.86
Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation. Adv Virus Res (2014) 0.86
Noncoding RNPs of viral origin. Cold Spring Harb Perspect Biol (2011) 0.86
BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator. Rev Med Virol (2013) 0.85
The Role of microRNAs in the Pathogenesis of Herpesvirus Infection. Viruses (2016) 0.85
Multiple functions are mediated by the miRNAs of Epstein-Barr virus. Curr Opin Virol (2014) 0.84
Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy. Int J Mol Sci (2013) 0.83
EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival. PLoS Pathog (2015) 0.83
Innate immune modulation in EBV infection. Herpesviridae (2011) 0.81
Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens. Oncotarget (2016) 0.80
A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog. PLoS Pathog (2016) 0.79
Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis. Medicine (Baltimore) (2016) 0.78
Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients. Emerg Microbes Infect (2015) 0.78
MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma. BMC Cancer (2016) 0.78
Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma. Oncotarget (2016) 0.78
Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Int J Cancer (2016) 0.77
Retracted Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses. Proc Natl Acad Sci U S A (2015) 0.77
Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue. Head Neck Pathol (2009) 0.76
The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma. J Cancer (2017) 0.75
The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation. Nucleic Acids Res (2015) 0.75
Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis. Autoimmune Dis (2011) 0.75
Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas. Cancer Med (2017) 0.75
Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines. BMC Genomics (2016) 0.75
MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet (2004) 37.83
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet (2008) 32.08
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res (2005) 29.17
Identification of microRNAs of the herpesvirus family. Nat Methods (2005) 12.98
Identification of virus-encoded microRNAs. Science (2004) 12.56
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA (2004) 11.52
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol (1990) 6.23
miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One (2007) 5.43
Epstein-Barr virus: exploiting the immune system. Nat Rev Immunol (2001) 5.08
Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog (2006) 4.80
A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA (2006) 4.47
Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol (1981) 4.39
Infectious mononucleosis. Clinical manifestations in relation to EB virus antibodies. JAMA (1968) 4.26
MicroRNA: implications for cancer. Virchows Arch (2007) 3.17
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV. Int J Cancer (1971) 2.96
Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol (2007) 2.88
Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res (2007) 2.74
Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A (2007) 2.64
EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res (2008) 2.46
Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol (1988) 2.37
Identification of microRNAs and other tiny noncoding RNAs by cDNA cloning. Methods Mol Biol (2004) 1.92
Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol (1991) 1.91
Epstein-Barr virus: adaptation to a life within the immune system. Trends Microbiol (1994) 1.90
Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma. EMBO J (2002) 1.89
Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol (1993) 1.88
Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol (2006) 1.62
Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol (2000) 1.57
Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. J Virol (2007) 1.53
Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol (2008) 1.51
Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology (1992) 1.47
Strategies for profiling microRNA expression. J Cell Physiol (2009) 1.41
Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer (2006) 1.41
EBV the prototypical human tumor virus--just how bad is it? J Allergy Clin Immunol (2005) 1.38
Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J Virol (1989) 1.34
Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. Semin Cancer Biol (1996) 1.27
MicroRNAs in diseases and drug response. Curr Opin Pharmacol (2008) 1.23
Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Virology (2004) 1.01
Epstein-Barr virus infection in the neonatal period and in childhood. Can Med Assoc J (1974) 0.92
In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders. J Gen Virol (2003) 0.91
Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A (2010) 6.72
Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol (2005) 3.16
EBV and systemic lupus erythematosus: a new perspective. J Immunol (2005) 2.34
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A (2003) 2.31
Sustained small interfering RNA-mediated human immunodeficiency virus type 1 inhibition in primary macrophages. J Virol (2003) 2.26
The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog (2009) 1.86
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion. Proc Natl Acad Sci U S A (2007) 1.82
The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity (2002) 1.56
Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol (2004) 1.48
The intersection of Epstein-Barr virus with the germinal center. J Virol (2009) 1.37
Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells. J Virol (2004) 1.36
On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood (2007) 1.36
Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. Immunity (2005) 1.36
Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc Natl Acad Sci U S A (2005) 1.34
Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J Virol (2007) 1.31
Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9. BMC Cancer (2006) 1.26
A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog (2011) 1.26
Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Med Virol (2005) 1.23
Localization of the Epstein-Barr virus protein LMP 1 to exosomes. J Gen Virol (2003) 1.16
Influence of EBV on the peripheral blood memory B cell compartment. J Immunol (2007) 1.12
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest (2012) 1.12
Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. J Virol (2005) 1.12
Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350. J Virol (2005) 1.05
Germinal center B cells latently infected with Epstein-Barr virus proliferate extensively but do not increase in number. J Virol (2009) 1.04
Broad cross-reactive TCR repertoires recognizing dissimilar Epstein-Barr and influenza A virus epitopes. J Immunol (2010) 1.00
Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology (2010) 0.98
Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J Med Virol (2010) 0.96
In nasopharyngeal carcinoma cells, Epstein-Barr virus LMP1 interacts with galectin 9 in membrane raft elements resistant to simvastatin. J Virol (2005) 0.94
Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol (2012) 0.93
EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. Virol J (2005) 0.92
Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol (2011) 0.92
A virtual look at Epstein-Barr virus infection: biological interpretations. PLoS Pathog (2007) 0.90
Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity. Cancer Res (2008) 0.89
Epstein-Barr virus replication in tongue epithelial cells. J Gen Virol (2002) 0.89
Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics. J Med Virol (2014) 0.87
Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay. J Clin Microbiol (2003) 0.86
Chemotaxis in densely populated tissue determines germinal center anatomy and cell motility: a new paradigm for the development of complex tissues. PLoS One (2011) 0.86
Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivo. Methods Mol Biol (2005) 0.85
An orthotopic model of metastatic nasopharyngeal carcinoma and its application in elucidating a therapeutic target that inhibits metastasis. Genes Cancer (2011) 0.83
Analysis of viral microRNA exchange via exosomes in vitro and in vivo. Methods Mol Biol (2013) 0.82
Absence of caspase 3 activation in neoplastic cells of nasopharyngeal carcinoma biopsies predicts rapid fatal outcome. Mod Pathol (2005) 0.82
Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30. Infect Agent Cancer (2010) 0.81
The cycle of EBV infection explains persistence, the sizes of the infected cell populations and which come under CTL regulation. PLoS Pathog (2013) 0.79
Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma. J Med Virol (2012) 0.78
Pathogens cooperate in lymphomagenesis. Nat Med (2007) 0.78
Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. J Med Virol (2003) 0.75
IFN-alpha-stimulated genes and Epstein-Barr virus gene expression distinguish WHO type II and III nasopharyngeal carcinomas. Cancer Res (2007) 0.75